AAP
CABA icon

Arax Advisory Partners’s Cabaletta Bio CABA Stock Holding History

Arax Advisory Partners’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31 Buy
10
+8
+400% +$26 ﹤0.01% 5170
2026
Q1 		$27 Sell
2
-8
-80% -$22 ﹤0.01% 3697
2025
Q4 		$22 Hold
10
– – ﹤0.01% 4011
2025
Q3 		$23 Buy
+10
New +$17 ﹤0.01% 3570

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Arax Advisory Partners's CABA Position: Q2 2026 in Review

Arax Advisory Partners increased its Cabaletta Bio (CABA) stake by 400% in Q2 2026, buying an estimated $26 and bringing the position to 10 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #5170.

Arax Advisory Partners first reported a position in CABA in Q3 2025 and has held it in 4 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Arax Advisory Partners held 10 shares of Cabaletta Bio worth $31 as of Q2 2026.
  • Arax Advisory Partners bought 8 Cabaletta Bio shares in Q2 2026, an estimated $26.
  • Cabaletta Bio made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #5170 holding.
  • Arax Advisory Partners first reported a position in Cabaletta Bio in Q3 2025 and has held it in 4 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.